Latest Prostate cancer Stories
Catalent, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is collaborating with
Fast paced sales growth sets a new company record and underscores the continued worldwide acceleration in demand for SonaCare’s unique HIFU platform technology. Charlotte,
Gallus BioPharmaceuticals, LLC, a premier, full service biopharmaceutical contract development and manufacturing organization announced today that it has been selected by Progenics Pharmaceuticals,
ENSPIRIT Trial to Continue as Planned Following Completion of the First of Two Interim Futility Analyses BOTHELL, Wash. and VANCOUVER, British Columbia, Aug.
Funding To Increase Manufacturing Capacity for Ramp-Up of Programs BETHESDA, Md., Aug.
Ablative device manufacturer sponsors international focal therapy symposium, highlights HIFU sessions and invites international attendees to connect with key opinion leaders and company management.
Company Strengthens Intellectual Property Protection in Additional Global Market DALLAS and NEW YORK, Aug. 14, 2014 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC.
Obesity increases a person’s risk of developing 10 of the most common forms of cancer, and is believed to cause an estimated 12,000 additional cases of the disease each year.
North Texas Chapter of the Association of Clinical Research Professionals and Baylor Research Institute, join with Myriad Genetics, Lynch Syndrome International, Progeny and Ambry Genetics to
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.
More Images (2 images) »